(Q73112568)

English

Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)

scientific article published on 01 June 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

object named as

F Cavalli

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

J Bernhard

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Castiglione-Gertsch

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S F Schmitz

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Thürlimann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Morant

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M F Fey

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Bonnefoi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Goldhirsch

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Hürny

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

913-920

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

On the receiving end--III. Measurement of quality of life during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Applications of global statistics in analysing quality of life data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Health complaints, stress, and distress: exploring the central role of negative affectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Coping with chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Missing quality of life data in cancer clinical trials: serious problems and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifying the types of missingness in quality of life data from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900028-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(99)00028-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533471%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73112568&oldid=1962227303"